Regarding the algorithm for the diagnosis of early mycosis fungoides proposed by the International Society for Cutaneous Lymphomas: suggestions from routine histopathology practice
- PMID: 18201238
- DOI: 10.1111/j.1600-0560.2007.00858.x
Regarding the algorithm for the diagnosis of early mycosis fungoides proposed by the International Society for Cutaneous Lymphomas: suggestions from routine histopathology practice
Abstract
Background: Routine clinicopathologic practice is expected to refine/validate the scoring system proposed in 2005 by the International Society for Cutaneous Lymphomas (ISCL) for the diagnosing early mycosis fungoides (eMF), classical type.
Methods: An evaluation of 72 cases of erythematous and scaling dermatoses was employed with a partial implementation of the ISCL algorithm.
Results: The selected cases fulfilled the clinical criteria proposed by the ISCL; routine histopathology allowed to reach the ISCL minimum score for a diagnosis of eMF in 45 cases. A clonal T-cell population was found in 4 out of 12 cases tested with the polymerase chain reaction, three of which with an already established clinicopathologic diagnosis of eMF. An aberrant immunophenotype was found in 11 cases, all of which already labeled as eMF on the basis of clinical and histopathologic features. 6 out of 27 patients with inconclusive clinicopathologic data underwent a new skin biopsy, which allowed to reach a diagnosis of eMF in two cases.
Conclusions: The diagnosis of eMF still rests upon clinical features and conventional histology; a new skin biopsy is recommended for cases with no clear-cut diagnostic features.
Similar articles
-
Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.Arch Dermatol. 1995 Sep;131(9):1027-31. Arch Dermatol. 1995. PMID: 7661604
-
Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: implications for diagnosis of mycosis fungoides in community clinical practice.J Am Acad Dermatol. 2001 Sep;45(3):405-13. doi: 10.1067/mjd.2001.116342. J Am Acad Dermatol. 2001. PMID: 11511839
-
T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.Australas J Dermatol. 2007 Aug;48(3):156-60. doi: 10.1111/j.1440-0960.2007.00370.x. Australas J Dermatol. 2007. PMID: 17680965
-
Early-stage mycosis fungoides variants: case-based review.Ann Diagn Pathol. 2010 Oct;14(5):369-85. doi: 10.1016/j.anndiagpath.2010.06.003. Ann Diagn Pathol. 2010. PMID: 20850703 Review.
-
Defining early mycosis fungoides.J Am Acad Dermatol. 2005 Dec;53(6):1053-63. doi: 10.1016/j.jaad.2005.08.057. J Am Acad Dermatol. 2005. PMID: 16310068 Review.
Cited by
-
Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update.An Bras Dermatol. 2012 Nov-Dec;87(6):817-28; quiz 829-30. doi: 10.1590/s0365-05962012000600001. An Bras Dermatol. 2012. PMID: 23197199 Free PMC article. Review.
-
A case report of refractory advanced-stage mycosis fungoides: successful treatment and improved patient quality of life with mogamulizumab.Ther Adv Hematol. 2024 Jul 30;15:20406207241260340. doi: 10.1177/20406207241260340. eCollection 2024. Ther Adv Hematol. 2024. PMID: 39091322 Free PMC article.
-
Defining the mimics and clinico-histological diagnosis criteria for mycosis fungoides to minimize misdiagnosis.Int J Womens Dermatol. 2017 Jan 30;3(2):100-106. doi: 10.1016/j.ijwd.2016.11.006. eCollection 2017 Jun. Int J Womens Dermatol. 2017. PMID: 28560304 Free PMC article.
-
34 years' duration of poikilodermatous lesion.Postepy Dermatol Alergol. 2020 Jun;37(3):438-440. doi: 10.5114/ada.2020.95966. Epub 2020 Jul 16. Postepy Dermatol Alergol. 2020. PMID: 32792890 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical